Skip to main content

The effects of alpha-lipoic acid on diabetic myopathy

Journal of Endocrinological Investigation volume 41, pages 203–209 (2018)Cite this article

Abstract

Purpose

Increased oxidative stress and impaired antioxidant defense are important mechanisms in the pathogenesis of diabetic myopathy. Since diabetes mellitus type 1 decreases muscle regeneration capacity the present study was designed to determine the influence of alpha-lipoic acid (ALA), a potent biological antioxidant, on the process of regeneration of diabetic rat skeletal muscles.

Methods

40 Wistar rats were divided into three groups: control (n = 8), untreated diabetic group (n = 16) and ALA treated diabetic group (n = 16). The regeneration process was provoked in streptozotocin-induced diabetic rats in both slow (m.soleus, SOL) and fast (m.extensor digitorum longus, EDL) skeletal muscles by intramuscular injection of myotoxin bupivacaine. At intervals of 10 days and 4 weeks, muscle histochemical and morphometrical analysis (fiber cross areas and fiber type distribution) was performed.

Results

Changes induced by diabetes are evident in redistribution of muscle fibers and in significant level of atrophy. After 4 weeks of diabetes, glycolytic muscle fibers are dominant in both slow and fast muscles. Muscle atrophy is present in all fiber types except in type I of slow skeletal muscle. Treatment with ALA reduce changes in the morphological properties caused by diabetes mellitus type 1 in slow and fast rat skeletal muscles during the process of regeneration.

Conclusion

Treatment with lipoic acid during 4 weeks has shown effects on the redistribution of muscle fibers, and can prevent atrophy in slow and fast diabetic muscle.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

References

  1. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820. doi:10.1038/414813a

    CAS  Article  PubMed  Google Scholar 

  2. Fahim MA, El-Sabban F, Davidson N (1998) Muscle contractility decrement and correlated morphology during the pathogenesis of streptozotocin-diabetic mice. Anat Rec 251:240–244

    CAS  Article  PubMed  Google Scholar 

  3. Jerkovic R, Bosnar A, Jurisic-Erzen D, Azman J, Starcevic-Klasan G, Peharec S, Coklo M (2009) The effects of long-term experimental diabetes mellitus type 1 on skeletal muscle regeneration capacity. Coll Antropol 33(4):1115–1119

    PubMed  Google Scholar 

  4. Ozaki K, Matsuura T, Narama I (2001) Histochemical and morphometrical analysis of skeletal muscle in spontaneous diabetic WBN/Kob rat. Acta Neuropathol 102:264–270

    CAS  PubMed  Google Scholar 

  5. Klueber KM, Feczko JD, Schmidt G, Watkins JB 3rd (1989) Skeletal muscle in the diabetic mouse: histochemical and morphometric analysis. Anat Rec 225:41–45. doi:10.1002/ar.1092250107

    CAS  Article  PubMed  Google Scholar 

  6. Rutschmann M, Dahlmann B, Reinauer H (1984) Loss of fast-twitch isomyosin in skeletal muscles of the diabetic rat. Biochem J 221:645–650

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. Jerkovic R, Argentini C, Serrano-Sanchez A, Cordonnier C, Schiaffino S (1997) Early myosin switching induced by nerve activity in regenerating slow skeletal muscle. Cell Struct Funct 22(1):147–153

    CAS  Article  PubMed  Google Scholar 

  8. Schiaffino S, Serrano AL, Jerkovic R, Di Lisi R, Murgia M (1998) Neural regulation of myosin gene expression in regenerating skeletal muscle. Acta Physiol Scand 163(3):S11–S15

    CAS  Article  PubMed  Google Scholar 

  9. Hall-Craggs EC (1974) Rapid degeneration and regeneration of a whole skeletal muscle following treatment with bupivacaine (Marcain). Exp Neurol 43:349–358

    CAS  Article  PubMed  Google Scholar 

  10. Barnard RJ, Youngren JF (1992) Regulation of glucose transport in skeletal muscle. FASEB J 6:3238–3244

    CAS  Article  PubMed  Google Scholar 

  11. Halseth AE, Bracy DP, Wasserman DH (2001) Functional limitations to glucose uptake in muscles comprised of different fiber types. Am J Physiol Endocrinol Metab 280:E994–E999

    CAS  Article  PubMed  Google Scholar 

  12. Packer L, Witt EH, Tritschler HJ (1995) alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227–250

    CAS  Article  PubMed  Google Scholar 

  13. Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A (2000) Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43:294–303

    CAS  Article  PubMed  Google Scholar 

  14. Biewenga GP, Haenen GR, Bast A (1997) The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 29(3):315–331

    CAS  Article  PubMed  Google Scholar 

  15. Estrada DE, Ewart HS, Tsakiridis T, Volchuk A, Ramlal T, Tritschler H, Klip A (1996) Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signalling pathway. Diabetes 45(12):1798–1804

    CAS  Article  PubMed  Google Scholar 

  16. Khamaisi M, Potashnik R, Tirosh A, Demshchak E, Rudich A, Tritschler H, Wessel K, Bashan N (1999) Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats. Metabolism 46(7):763–768

    Article  Google Scholar 

  17. Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, Dietze GJ (1995) Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 45(8):872–874

    CAS  PubMed  Google Scholar 

  18. Papanas N, Ziegler D (2014) Efficacy of Alpha-lipoic acid in diabetic neuropathy. Expert Opin Pharmacother 15(18):2721–2731. doi:10.1517/14656566.2014.972935

    CAS  Article  PubMed  Google Scholar 

  19. Golbidi S, Badran M, Laher I (2011) Diabetes and alpha lipoic acid. Front Pharmacol 2(69):1–15. doi:10.3389/fphar.2011.00069

    Google Scholar 

  20. Coleman SK, Rebalka IA, D’Souza DM, Hawke TJ (2015) Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications. World J Diabetes 6(17):1323–1336. doi:10.4239/wjd.v6.i17.1323

    Article  PubMed  PubMed Central  Google Scholar 

  21. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signalling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23(5):599–622. doi:10.1210/er.2001-0039

    CAS  Article  PubMed  Google Scholar 

  22. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865):799–806. doi:10.1038/414799a

    CAS  Article  PubMed  Google Scholar 

  23. Wieteska-Skrzeczynska W, Grzelkowska-Kowalczyk K, Jank M, Maciejewski H (2009) Transcriptional dysregulation of skeletal muscle protein metabolism in streptozotocin-diabetic mice. J Physiol Pharmacol 60(Suppl 1):29–36

    PubMed  Google Scholar 

  24. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J (2000) Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 26(3):163–176

    CAS  PubMed  Google Scholar 

  25. Cariello A (2003) New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 26(5):1589–1596

    Article  Google Scholar 

  26. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schütte K, Kerum G, Malessa R (1999) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 22(8):1296–1301

    CAS  Article  PubMed  Google Scholar 

  27. Panigrahi M, Sadguna Y, Shivakumar BR, Kolluri SV, Roy S, Packer L, Ravindranath V (1996) Alpha lipoic protects against reperfusion injury following cerebral ischemia in rats. Brain Res 717(1–2):79–101

    Google Scholar 

  28. Koçak G, Aktan F, Canbolat O, Ozoğul C, Elbeğ S, Yildizoglu-Ari N, Karasu C, ADIC Study Group-Antioxidants in Diabetes-Induced Complications (2000) Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab 13(6):308–318

    PubMed  Google Scholar 

  29. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, Klip A (2001) The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50(6):1464–1470

    CAS  Article  PubMed  Google Scholar 

  30. Shen QW, Jones CS, Kalchayanand N, Zhu MJ, Du M (2005) Effect of dietary alpha-lipoic acid on growth, body composition, muscle pH, and AMP-activated protein kinase phosphorylation in mice. J Anim Sci 83(11):2611–2617

    CAS  Article  PubMed  Google Scholar 

  31. Lee WJ, Song KH, Koh EH, Won JC, Kim HS, Park HS, Kim MS, Kim SW, Lee KU, Park JY (2005) Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun 332(3):885–891. doi:10.1016/j.bbrc.2005.05.035

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

We specially thank Prof. Stefano Sciaffino from the Department of Biomedical Sciences, Padua, Italy for supplying us with monoclonal antibodies for slow and fast myosin heavy chain isoforms.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Clinical Hospital Centre Rijeka, Kresimirova 42, 51000, Rijeka, Croatia

    D. Jurisic-Erzen

  2. Department of Anatomy, Faculty of Medicine, University of Rijeka, Brace Branchetta 20, 51000, Rijeka, Croatia

    G. Starcevic-Klasan & R. Jerkovic

  3. Department of Traumatology, Clinical Hospital Centre Rijeka, Tome Strizica 3, 51000, Rijeka, Croatia

    D. Ivanac

  4. Polyclinic of Physical Medicine and Rehabilitation, Rizzijeva 101, 52000, Pula, Croatia

    S. Peharec

  5. Department of Neurosurgery, Clinical Hospital Centre Rijeka, Tome Strizica 3, 51000, Rijeka, Croatia

    D. Girotto

Authors
  1. D. Jurisic-Erzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Starcevic-Klasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Ivanac
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Peharec
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Girotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Jerkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceived and designed the experiments: SKG, ID, JED, JR. Performed experiments: SKG, ID, JR, JED. Analysed the data: JR, JED, PS, GD. Contributed reagents/analysis tools: JR, JED, PS, GD. Wrote the paper: SKG, JR, JED. All authors read and approved the final manuscript.

Corresponding author

Correspondence to G. Starcevic-Klasan.

Ethics declarations

Funding

The design, collection, analysis, interpretation of data and manuscript writing of the study was supported by a Grant from the University of Rijeka, Croatia No. 848-10-1348.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures using animals in this investigation were approved by the Animal Ethics Committee of the Faculty of Medicine, University of Rijeka and are in accordance with the Law on the implementation of European Union Regulations on animal welfare 2013.

Informed consent

No informed consent.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jurisic-Erzen, D., Starcevic-Klasan, G., Ivanac, D. et al. The effects of alpha-lipoic acid on diabetic myopathy. J Endocrinol Invest 41, 203–209 (2018). https://doi.org/10.1007/s40618-017-0720-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-017-0720-0

Keywords

  • Skeletal muscle
  • Regeneration
  • Diabetes mellitus type 1
  • Alpha-lipoic acid